REG-Capital Increase in Genmab as a Result of Employee Warrant Exercise
Globe Newswire•10/11/2026•15:32 ET
0
Key Highlights
- ➤Genmab will issue 164,828 shares through employee warrant exercises.
- ➤Warrant exercise proceeds total approximately DKK 369.7 million.
- ➤Capital increase represents approximately 0.2641% of Genmab’s share capital.
- ➤Post-increase share capital totals DKK 62,570,683, comprising 62,570,683 shares.
COPENHAGEN, Denmark; November 10, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 164,828 shares as a consequence of the exercise of employee warrants.
The increase is effected without any preemption rights for the existing shareholders of the Company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:
Get started
Create a free account to read the full story.